Vanguard Developed Markets Index Fund Inst (VTMNX)
17.85
+0.10
(+0.56%)
USD |
May 29 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.03% | 214.07B | 2.91% | 3.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 9.042B | 14.93% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe and the Pacific Region. The Fund employs an indexing investment approach designed to track the performance of FTSE Developed All Cap ex US Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Multi-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Vanguard |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
2
-429.31M
Peer Group Low
513.11M
Peer Group High
1 Year
% Rank:
2
9.042B
-2.358B
Peer Group Low
9.042B
Peer Group High
3 Months
% Rank:
2
-498.76M
Peer Group Low
1.369B
Peer Group High
3 Years
% Rank:
2
-3.073B
Peer Group Low
26.31B
Peer Group High
6 Months
% Rank:
4
-1.184B
Peer Group Low
4.582B
Peer Group High
5 Years
% Rank:
2
-94.00B
Peer Group Low
47.38B
Peer Group High
YTD
% Rank:
3
-983.15M
Peer Group Low
2.588B
Peer Group High
10 Years
% Rank:
4
-47.30B
Peer Group Low
120.39B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 30, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.19% |
| Stock | 97.82% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.35% |
| Other | 1.63% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Vanguard Market Liquidity Fund
|
1.56% | -- | -- |
| SAP SE | 1.32% | 302.00 | 1.97% |
| Nestle SA | 1.12% | 106.13 | -0.52% |
| ASML Holding NV | 1.06% | 735.82 | -1.28% |
| Novartis AG | 0.92% | 110.25 | -1.82% |
| Roche Holding AG | 0.92% | 323.35 | 0.76% |
| Toyota Motor Corp | 0.91% | 19.00 | 2.14% |
| AstraZeneca PLC | 0.88% | 143.20 | 0.07% |
| Novo Nordisk AS | 0.88% | 70.60 | 2.02% |
| HSBC Holdings PLC | 0.82% | 11.75 | 0.00% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.02% |
| Administration Fee | 5.40M% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 5.00M None |
| Minimum Subsequent Investment | 1.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe and the Pacific Region. The Fund employs an indexing investment approach designed to track the performance of FTSE Developed All Cap ex US Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Multi-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Vanguard |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-29-25) | 2.81% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 22.87 |
| Weighted Average Price to Sales Ratio | 3.874 |
| Weighted Average Price to Book Ratio | 3.683 |
| Weighted Median ROE | 15.41% |
| Weighted Median ROA | 5.75% |
| ROI (TTM) | 10.51% |
| Return on Investment (TTM) | 10.51% |
| Earning Yield | 0.0630 |
| LT Debt / Shareholders Equity | 0.7308 |
As of April 30, 2025
Growth Metrics
| EPS Growth (1Y) | 16.06% |
| EPS Growth (3Y) | 10.86% |
| EPS Growth (5Y) | 10.19% |
| Sales Growth (1Y) | 6.96% |
| Sales Growth (3Y) | 8.81% |
| Sales Growth (5Y) | 6.92% |
| Sales per Share Growth (1Y) | 9.46% |
| Sales per Share Growth (3Y) | 9.67% |
| Operating Cash Flow - Growth Ratge (3Y) | 8.25% |
As of April 30, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:VTMNX", "name") |
| Broad Asset Class: =YCI("M:VTMNX", "broad_asset_class") |
| Broad Category: =YCI("M:VTMNX", "broad_category_group") |
| Prospectus Objective: =YCI("M:VTMNX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |